Exploring the Mechanism of Indigo Naturalis in the Treatment of Ulcerative Colitis Based on TLR4/MyD88/NF-κB Signaling Pathway and Gut Microbiota

Background: Clinical trials have proven that indigo naturalis is a candidate drug for treating ulcerative colitis (UC), but its therapeutic mechanism is still unclear. Purpose: This study aimed to evaluate the protective effect and mechanism of indigo naturalis to treat mice with dextran sulfate sod...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Qi-yue, Ma, Le-le, Zhang, Chen, Lin, Jun-zhi, Han, Li, He, Ya-nan, Xie, Chun-guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339204/
https://www.ncbi.nlm.nih.gov/pubmed/34366843
http://dx.doi.org/10.3389/fphar.2021.674416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339204/
https://www.ncbi.nlm.nih.gov/pubmed/34366843
http://dx.doi.org/10.3389/fphar.2021.674416

Ejemplares similares